US Patent

US9090562 — Aryl- or heteroaryl-substituted benzene compounds

Composition of Matter · Assigned to Epizyme Inc · Expires 2031-09-12 · 5y remaining

Vulnerability score 10/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects aryl- or heteroaryl-substituted benzene compounds, including their pharmaceutical compositions and methods of treating cancer.

USPTO Abstract

The present invention relates to aryl- or heteroaryl-substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

Drugs covered by this patent

Patent Metadata

Patent number
US9090562
Jurisdiction
US
Classification
Composition of Matter
Expires
2031-09-12
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Epizyme Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.